Кыргызская Государственная Медицинская Академия им. И. К. Ахунбаева, кафедра базисной и клинической фармакологии, Бишкек, Кыргызская Республика Резюме статья
КАЧЕСТВЕННАЯ КЛИНИЧЕСКАЯ ПРАКТИКА №1 2015 г
жүктеу/скачать 0,75 Mb. Pdf көрінісі
|
| 91
КАЧЕСТВЕННАЯ КЛИНИЧЕСКАЯ ПРАКТИКА №1 2015 г. Литература 1. Чучалин А.Г., Шухов В.С., Харпер Дж.Р. Формуляр лекарственных средств: проблемные вопросы. // Русский медицинский журнал. 1999 г, № 12, С. 535-542. http://www.rmj.ru/articles_1912.htm. 2. Декларации о правах пациентов в России ( принята на Первом Всероссийском конгрессе пациентов 28 мая 2010 года в Москве ). Москва, 2010. http://www.patients.ru/en/patients/rights-declarations. 3. Dukes M.N.G., Swartz B. Responsibility for drug-induced injury. Amsterdam: Elsevier, 1988. 4. Политика в области информации о лекарственных средствах в странах центральной и восточной Европы и в Новых Независимых Государ- ствах — Отчет о рабочем совещании ВОЗ. Хиллеред, Дания, 27.03—02.04.1996. 5. De Vries T.P.G.M., Henning R.H., Hogerzeil H.V., Fresle D.A. Guide to Good Prescribing. WHO, Geneva, 1995. 6. Wubben D.P., Vivian E.M. Eff ects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. // Pharmacotherapy. 2008 Apr;28(4):421-36. doi: 10.1592/phco.28.4.421. Review. 7. Oenning D., Oliveira B.V., Blatt C.R. Patient awareness about drugs prescribed aft er medical appointment and prescription [Article in Portuguese]. // Cien Saude Colet. 2011 Jul;16(7):3277-83. 8. Celik E., Nazh M., Encan M., Clark P. Review: Factors aff ecting rational drug use (RDU), compliance and wastage. // Turk J. Pharm. Sci. 10 (1), 15-170, 2013. 9. Sankaravadivu T., Samjeeva kumar E., Bhavya E. A Prospective Study on Rational Drug Use and Th e Essential Drug Concept. // International Journal of Research in Pharmaceutical and Biomedical Sciences. — Vol. 2 (2) Apr — Jun 2011. 10. Goldsmith C.H. (1979) Th e eff ect of compliance distributions on therapeutic trials. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in HealthCare. Baltimore: John Hopkins University Press, 63-77. 11. Donovan J.L., Blake D.R. (1992) Patient non-compliance: deviance or reasoned decision-making? Social Science and Medicine, 34, 507-513. 12. Michael Ho P., Bryson Chris L., Rumsfeld John S. Medication Adherence. Its Importance in Cardiovascular Outcomes. // Circulation. 2009;119:3028-3035. 13. Haynes R.B., McKibbon K.A., Kanani R., Brouwers M.C., Oliver T. (1997) Interventions to Assist Patients to Follow Prescriptions for Medications. Oxford: Th e Cochrane Collaboration. Update Soft ware. 14. Horne R. (1997) Representation of medication and treatment: advances in theory and measurements. In: Petrie R, Weinlan J, eds. (1997) Perceptions of Health and Illness: Current Research and Applications. London: Harwood Academic, 155-188. 15. Donovan J.L. (1995) Patient decision making. Th e missing ingredient in compliance research. // International Journal of Technology Assessment in Health Care, 11, 443±445. 16. Steiner A., Vetter W. (1994) Patient-Compliance/non-Compliance, bestimmende Faktoren, Artz-PatientInteraktion. Schweizerische Rundschau fur Medizin Praxis, 83, 889±889. 17. Marinker M. (1997) From Compliance to Concordance. Achieving Shared Goals in Medicine Taking. London: Royal Pharmaceutical Society of Great Britain. 18. Haynes B., Taylor D.W., Sackett D.L. (1979) Compliance in Health Care. Baltimore: Th e John Hopkins University Press. 19. Kaplan H.I., Greenfi eld S., Ware J.E. Jr. Assessing the eff ects of physician-patient interactions on the outcomes of chronic disease. // Med. Care. 1989. Vol. 27. № 3. Suppl. P. S110—S127. 20. Незнанов Н.Г., Вид В.Д. Проблема комплаенса в клинической психиатрии. // Психиатрия и психофармакотерапия. 2004. Т. 6. № 4. C. 2—10. 21. Geller J.L. State hospital patients and their medication — do they know what they take? // Am. J. Psychiatry. 1982. Vol. 139. № 5. P. 611—615. 22. Osterberg L., Blaschke T. Adherence to Medication. // N Engl J Med 2005;353:487-97. 23. Cegala D.J., Marinelli T., Post D. Th e Eff ects of Patient Communication Skills Training on Compliance. // Arch Fam Med. 2000;9:57-64. 24. Coral Sirdifi eld, Sibyl Anthierens, Hanne Creupelandt, Susan Y Chipchase, Th ierry Christiaens and Aloysius Niroshan Siriwardena. General practitioners’ experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. // BMC Family Practice . 2013, 14:191. http://www. biomedcentral.com/1471-2296/14/191. 25. Gazmararian J.A., Kripalani S., Miller M.J., Echt K.V., Ren J., Rask K. Factors associated with medication refi ll adherence in cardiovascular-related diseases Journal of General Internal Medicine, December 2006, Volume 21, Issue 12, pp 1215-1221. 26. Sencan N.M., Wertheimer A.I., Levine C.B. What determines the duration of patient medication compliance in patients with chronic disease: are we looking in the wrong place? Southern Med Review 4(2), 50-54, 2011. 27. Vermeire E., Hearnshaw H., Van Royen P. and Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review (REVIEW ARTICLE). //Journal of Clinical Pharmacy and Th erapeutics (2001) 26, 331-342. 28. Carol D. Tamparo, Wilburta Q. Lindh. Th erapeutic Communications for Health Care Paperback — July 24, 2007. 29. Demyttenaere K. Compliance during treatment with antidepressants // J. Aff ect. Disord. 1997. Vol. 43. № 1. P. 27—39. Osterberg L., Blaschke T. Adherence to medication. // N Engl J Med. 2005;353:487—497. 30. Epstein R.M., Borrell F., Caterina M. Communication and mental health in primary care. In New Oxford Textbook of Psychiatry (Edrs. Gelder MG, L?pez- Ibor JJ, Andreasen NC), Oxford University Press, 2000. 31. Sankar P. Communication and Miscommunication in Informed Consent to Research. // Medical Anthropology Quarterly 18(4): 429-446. 32. Baumann M., жүктеу/скачать 0,75 Mb. Достарыңызбен бөлісу:
|